No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Precision OS Announces Professor Richard Satava as Key Simulation Advisor

Editor: What To Know

  • He is currently a member of the Technology Enhanced Surgical Education Committee of the American College of Surgeons (ACS), is past president of the Society of American Gastrointestinal Endoscopic Surgeons (SAGES) and the Society of Laparoendoscopic Surgeons (SLS), and is a former member of the National Board of Medical Examiners (NBME).
  • Satava, current Professor Emeritus of Surgery at the University of Washington, past Program Manager at Defense Advanced Research Projects Agency (DARPA) and former Senior Science Advisor for the US Army Medical Research Command, will bring his depth of experience to Precision OS and assist with implementing future upgrades and strategic simulation advancements to the software.
  • Satava has over 250 publications and book chapters in areas like advanced surgical technology, including Surgery in the Space Environment, Video and 3-D imaging, Telepresence Surgery, Virtual Reality Surgical Simulation, and Objective Assessment of Surgical Competence and Training.

Precision OS, developers of a medical-grade virtual reality™ learning platform, are excited to announce Dr. Richard Satava has joined their team of advisors.

In his role, Dr. Satava will provide his wealth of experience in simulation, research and surgical expertise toward the development of enhanced immersive training and education modules created by Precision OS.

As a highly experienced surgeon and active board member across countless medical organizations, Dr. Satava will provide invaluable interdisciplinary input and expertise through a simulation lens. Dr. Satava, current Professor Emeritus of Surgery at the University of Washington, past Program Manager at Defense Advanced Research Projects Agency (DARPA) and former Senior Science Advisor for the US Army Medical Research Command, will bring his depth of experience to Precision OS and assist with implementing future upgrades and strategic simulation advancements to the software.

“As a world-class expert in surgical simulation, I am extremely excited to welcome Dr. Satava to our team of advisors,” said Dr. Danny Goel, a practicing orthopedic surgeon in Vancouver, BC, and Chief Executive Officer of Precision OS. “To drive the mission of our company toward proficiency-based learning, it is essential for us to learn from an expert like Dr. Satava. His reputation precedes him, and we are fortunate to have his input in advancing global surgical education.”

Dr. Satava was instrumental in developing the first virtual reality surgical simulators and has extended expertise with advanced surgical technology, virtual reality, surgical simulation and surgical training.

He has also served on the White House Office of Science and Technology Policy (OSTP) Committee on Health, Food and Safety. He is currently a member of the Technology Enhanced Surgical Education Committee of the American College of Surgeons (ACS), is past president of the Society of American Gastrointestinal Endoscopic Surgeons (SAGES) and the Society of Laparoendoscopic Surgeons (SLS), and is a former member of the National Board of Medical Examiners (NBME).

“The Precision OS virtual reality training system is one of the most advanced surgical simulations, both visually and in terms of its highly realistic dynamic interactivity, that I have experienced throughout my career,” Dr. Satava said. “This combination is extremely rare, unique and ahead of its time, placing Precision OS in a crucial leadership position within the world of virtual reality surgical simulation.”

Dr. Satava has over 250 publications and book chapters in areas like advanced surgical technology, including Surgery in the Space Environment, Video and 3-D imaging, Telepresence Surgery, Virtual Reality Surgical Simulation, and Objective Assessment of Surgical Competence and Training.

“In his short time with our company, he has already had a significant impact on how we are thinking and developing our next-generation software platform,” Dr. Goel said. “His presence has already been noted across several domains in the technology we are creating.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy